OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
STAT3 pathway in cancers: Past, present, and future
Hanqi Wang, Qi‐Wen Man, Fang‐Yi Huo, et al.
MedComm (2022) Vol. 3, Iss. 2
Open Access | Times Cited: 100
Hanqi Wang, Qi‐Wen Man, Fang‐Yi Huo, et al.
MedComm (2022) Vol. 3, Iss. 2
Open Access | Times Cited: 100
Showing 26-50 of 100 citing articles:
A high-fat diet induces changes in mesenteric adipose tissue accelerating early-stage pancreatic carcinogenesis in mice
Aya Ead, Joanna Wirkus, Karen Matsukuma, et al.
The Journal of Nutritional Biochemistry (2024) Vol. 131, pp. 109690-109690
Open Access | Times Cited: 4
Aya Ead, Joanna Wirkus, Karen Matsukuma, et al.
The Journal of Nutritional Biochemistry (2024) Vol. 131, pp. 109690-109690
Open Access | Times Cited: 4
Small molecular inhibitors and degraders targeting STAT3 for cancer therapy: An updated review (from 2022 to 2024)
Zhaoyong Kang, Li Shen, Yan Li, et al.
Chinese Chemical Letters (2024), pp. 110447-110447
Closed Access | Times Cited: 4
Zhaoyong Kang, Li Shen, Yan Li, et al.
Chinese Chemical Letters (2024), pp. 110447-110447
Closed Access | Times Cited: 4
STAT3: Key targets of growth-promoting receptor positive breast cancer
Ruiyuan Jiang, Jiayu Zhu, Huanping Zhang, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 4
Ruiyuan Jiang, Jiayu Zhu, Huanping Zhang, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 4
Discovery of 2-Pyrazolines That Inhibit the Phosphorylation of STAT3 as Nanomolar Cytotoxic Agents
Tejaswini P. Siddappa, Akshay Ravish, Xi Zhang, et al.
ACS Omega (2025) Vol. 10, Iss. 1, pp. 114-126
Open Access
Tejaswini P. Siddappa, Akshay Ravish, Xi Zhang, et al.
ACS Omega (2025) Vol. 10, Iss. 1, pp. 114-126
Open Access
L3MBTL3 and STAT3 collaboratively upregulate SNAIL expression to promote metastasis in female breast cancer
J Xiao, Jie Wang, Jialun Li, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
J Xiao, Jie Wang, Jialun Li, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Discovery of Naphthoquinone-Furo-Piperidone Derivatives as Dual Targeting Agents of STAT3 and NQO1 for the Treatment of Breast Cancer
Shengying Lou, Chenjun Shen, Hao Ni, et al.
European Journal of Medicinal Chemistry (2025) Vol. 287, pp. 117377-117377
Closed Access
Shengying Lou, Chenjun Shen, Hao Ni, et al.
European Journal of Medicinal Chemistry (2025) Vol. 287, pp. 117377-117377
Closed Access
Targeting STAT3 for Cancer Therapy: Focusing on Y705, S727, or Dual Inhibition?
Kyli Berkley, Julian Zalejski, Ashutosh Sharma
Cancers (2025) Vol. 17, Iss. 5, pp. 755-755
Open Access
Kyli Berkley, Julian Zalejski, Ashutosh Sharma
Cancers (2025) Vol. 17, Iss. 5, pp. 755-755
Open Access
Jorunnamycin A induces apoptosis in pancreatic ductal adenocarcinoma cells, spheroids, and patient-derived organoids by modulating KRAS-mediated survival pathways
Hnin Ei Ei Khine, Utid Suriya, Thanyada Rungrotmongkol, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Hnin Ei Ei Khine, Utid Suriya, Thanyada Rungrotmongkol, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Molecular mechanisms underlying TXNIP’s anti-tumor role in breast cancer, including interaction with a novel, pro-tumor partner: CAST
Jasvinder A. Singh, Bindeshwar Sah, Yibin Deng, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access
Jasvinder A. Singh, Bindeshwar Sah, Yibin Deng, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access
The Potential Therapeutic Role of Beta-Caryophyllene as a Chemosensitizer and an Inhibitor of Angiogenesis in Cancer
Emad A. Ahmed
Molecules (2025) Vol. 30, Iss. 8, pp. 1751-1751
Open Access
Emad A. Ahmed
Molecules (2025) Vol. 30, Iss. 8, pp. 1751-1751
Open Access
MicroRNAs in Diffuse Large B-Cell Lymphoma (DLBCL): Biomarkers with Prognostic Potential
Yu. A. Veryaskina, С. Е. Титов, Igor B. Kovynev, et al.
Cancers (2025) Vol. 17, Iss. 8, pp. 1300-1300
Open Access
Yu. A. Veryaskina, С. Е. Титов, Igor B. Kovynev, et al.
Cancers (2025) Vol. 17, Iss. 8, pp. 1300-1300
Open Access
Extracts from Allium pseudojaponicum Makino Target STAT3 Signaling Pathway to Overcome Cisplatin Resistance in Lung Cancer
Soo-Bin Nam, Jung Hoon Choi, Ga-Eun Lee, et al.
Marine Drugs (2025) Vol. 23, Iss. 4, pp. 167-167
Open Access
Soo-Bin Nam, Jung Hoon Choi, Ga-Eun Lee, et al.
Marine Drugs (2025) Vol. 23, Iss. 4, pp. 167-167
Open Access
Novel inhibitors of STAT3: an updated patent review (2022–present)
Keting Bao, Peiran Li, Dingding Gao
Expert Opinion on Therapeutic Patents (2025)
Closed Access
Keting Bao, Peiran Li, Dingding Gao
Expert Opinion on Therapeutic Patents (2025)
Closed Access
STAT3 and Its Pathways’ Dysregulation—Underestimated Role in Urological Tumors
Maciej Golus, Piotr Bugajski, Joanna Chorbińska, et al.
Cells (2022) Vol. 11, Iss. 19, pp. 3024-3024
Open Access | Times Cited: 18
Maciej Golus, Piotr Bugajski, Joanna Chorbińska, et al.
Cells (2022) Vol. 11, Iss. 19, pp. 3024-3024
Open Access | Times Cited: 18
Modulatory properties of curcumin in cancer: A narrative review on the role of interferons
Sajjad Chamani, Maryam Moossavi, Ali Naghizadeh, et al.
Phytotherapy Research (2023) Vol. 37, Iss. 3, pp. 1003-1014
Open Access | Times Cited: 9
Sajjad Chamani, Maryam Moossavi, Ali Naghizadeh, et al.
Phytotherapy Research (2023) Vol. 37, Iss. 3, pp. 1003-1014
Open Access | Times Cited: 9
Cancer metastasis under the magnifying glass of epigenetics and epitranscriptomics
Maxime Janin, Verónica Dávalos, Manel Esteller
Cancer and Metastasis Reviews (2023) Vol. 42, Iss. 4, pp. 1071-1112
Open Access | Times Cited: 9
Maxime Janin, Verónica Dávalos, Manel Esteller
Cancer and Metastasis Reviews (2023) Vol. 42, Iss. 4, pp. 1071-1112
Open Access | Times Cited: 9
Exposure of human glioblastoma cells to thimerosal inhibits the thioredoxin system and decreases tumor growth-related factors
Isabella Bramatti, Michael Aschner, Vasco Branco, et al.
Toxicology and Applied Pharmacology (2024) Vol. 484, pp. 116844-116844
Open Access | Times Cited: 3
Isabella Bramatti, Michael Aschner, Vasco Branco, et al.
Toxicology and Applied Pharmacology (2024) Vol. 484, pp. 116844-116844
Open Access | Times Cited: 3
Pomegranate Peel Extract Sensitizes Hepatocellular Carcinoma Cells to Ionizing Radiation, Induces Apoptosis and Inhibits MAPK, JAK/STAT3, β-Catenin/NOTCH, and SOCS3 Signaling
M. M. Mahmoud, Nermeen M. ElBakary, Sanaa A. Hagag, et al.
Integrative Cancer Therapies (2023) Vol. 22, pp. 153473542211510-153473542211510
Open Access | Times Cited: 7
M. M. Mahmoud, Nermeen M. ElBakary, Sanaa A. Hagag, et al.
Integrative Cancer Therapies (2023) Vol. 22, pp. 153473542211510-153473542211510
Open Access | Times Cited: 7
Pharmacological anti-tumor effects of natural Chamaecyparis obtusa (siebold & zucc.) endl. Leaf extracts on breast cancer
Yong‐Jin Kwon, Eun‐Bi Seo, Seulki Kim, et al.
Journal of Ethnopharmacology (2023) Vol. 313, pp. 116598-116598
Open Access | Times Cited: 7
Yong‐Jin Kwon, Eun‐Bi Seo, Seulki Kim, et al.
Journal of Ethnopharmacology (2023) Vol. 313, pp. 116598-116598
Open Access | Times Cited: 7
Oligonucleotide-Based Therapeutics for STAT3 Targeting in Cancer—Drug Carriers Matter
Sara Molenda, Agata Sikorska, Anna Florczak, et al.
Cancers (2023) Vol. 15, Iss. 23, pp. 5647-5647
Open Access | Times Cited: 7
Sara Molenda, Agata Sikorska, Anna Florczak, et al.
Cancers (2023) Vol. 15, Iss. 23, pp. 5647-5647
Open Access | Times Cited: 7
Multifaceted roles for STAT3 in gammaherpesvirus latency revealed through in vivo B cell knockout models
Chad H. Hogan, Shana M. Owens, Glennys V. Reynoso, et al.
mBio (2024) Vol. 15, Iss. 2
Open Access | Times Cited: 2
Chad H. Hogan, Shana M. Owens, Glennys V. Reynoso, et al.
mBio (2024) Vol. 15, Iss. 2
Open Access | Times Cited: 2
Fucoxanthin induces human melanoma cytotoxicity by thwarting the JAK2 /STAT3 /BCL‐xL signaling axis
Min‐Yung Kuo, Wen‐Chyi Dai, Jie‐Li Chang, et al.
Environmental Toxicology (2024) Vol. 39, Iss. 6, pp. 3356-3366
Closed Access | Times Cited: 2
Min‐Yung Kuo, Wen‐Chyi Dai, Jie‐Li Chang, et al.
Environmental Toxicology (2024) Vol. 39, Iss. 6, pp. 3356-3366
Closed Access | Times Cited: 2
Enhancing cancer therapy: The role of drug delivery systems in STAT3 inhibitor efficacy and safety
Kangning Wang, Kan Zhou, Nian‐Nian Zhong, et al.
Life Sciences (2024) Vol. 346, pp. 122635-122635
Closed Access | Times Cited: 2
Kangning Wang, Kan Zhou, Nian‐Nian Zhong, et al.
Life Sciences (2024) Vol. 346, pp. 122635-122635
Closed Access | Times Cited: 2
Prognostic and therapeutic potential of STAT3: Opportunities and challenges in targeting HPV-mediated cervical carcinogenesis
Divya Janjua, Kulbhushan Thakur, Nikita Aggarwal, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 197, pp. 104346-104346
Closed Access | Times Cited: 2
Divya Janjua, Kulbhushan Thakur, Nikita Aggarwal, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 197, pp. 104346-104346
Closed Access | Times Cited: 2
Caffeic acid hinders the proliferation and migration through inhibition of IL-6 mediated JAK-STAT-3 signaling axis in human prostate cancer
Yuan Yin, Zhengyin Wang, YUJIE HU, et al.
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2024) Vol. 32, Iss. 12, pp. 1881-1890
Open Access | Times Cited: 2
Yuan Yin, Zhengyin Wang, YUJIE HU, et al.
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2024) Vol. 32, Iss. 12, pp. 1881-1890
Open Access | Times Cited: 2
